OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Empagliflozin activates Sestrin2-mediated AMPK/mTOR pathway and ameliorates lipid accumulation in obesity-related nonalcoholic fatty liver disease
Yuting Ma, Guangdong Zhang, Zenggguang Kuang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 21

Showing 21 citing articles:

Antioxidant and anti-inflammatory agents in chronic liver diseases: Molecular mechanisms and therapy
Chunye Zhang, Shuai Liu, Ming Yang
World Journal of Hepatology (2023) Vol. 15, Iss. 2, pp. 180-200
Open Access | Times Cited: 45

Recent advances in anti-inflammation via AMPK activation
Yihua Xu, Lan Bai, Xinwei Yang, et al.
Heliyon (2024) Vol. 10, Iss. 13, pp. e33670-e33670
Open Access | Times Cited: 13

Sestrin2 ameliorates age-related spontaneous benign prostatic hyperplasia via activation of AMPK/mTOR dependent autophagy
Hui-Ju Lee, Yae-Ji Kim, Hwan‐Woo Park, et al.
Biogerontology (2025) Vol. 26, Iss. 1
Closed Access

Therapeutic Potential of Sotagliflozin in Animal Models of Non-alcoholic Fatty Liver Disease with and without Diabetes
Nitin Deshmukh, M. S. Kalshetti, Mohan Patil, et al.
Drug Research (2025)
Closed Access

Epithelial Piezo1 deletion ameliorates intestinal barrier damage by regulating ferroptosis in ulcerative colitis
Jiejie Zhu, Yumei Wu, Luyao Zhang, et al.
Free Radical Biology and Medicine (2024) Vol. 224, pp. 272-286
Closed Access | Times Cited: 3

Update in non-alcoholic fatty liver disease management: role of sodium-glucose cotransporter 2 inhibitors
Oscar René Zambrano-Vásquez, Fernando Cortés-Camacho, Jorge Ismael Castañeda‐Sánchez, et al.
Life Sciences (2025), pp. 123638-123638
Closed Access

Recent Insights into the Biomarkers, Molecular Targets and Mechanisms of Non-Alcoholic Steatohepatitis-Driven Hepatocarcinogenesis
Anna Kakehashi, Shugo Suzuki, Hideki Wanibuchi
Cancers (2023) Vol. 15, Iss. 18, pp. 4566-4566
Open Access | Times Cited: 9

Sestrin2 as a Protective Shield against Cardiovascular Disease
Muhammad Zahid, Shahenda S. Abdelsalam, Hicham Raïq, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4880-4880
Open Access | Times Cited: 6

Role of dysfunctional peri-organ adipose tissue in metabolic disease
Kexin Zhang, Jingwen Zhang, Chengxia Kan, et al.
Biochimie (2023) Vol. 212, pp. 12-20
Closed Access | Times Cited: 5

Exercise ameliorates chronic inflammatory response induced by high-fat diet via Sestrin2 in an Nrf2-dependent manner
Sujuan Liu, Huige Li, Yukun Zhang, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 7, pp. 166792-166792
Open Access | Times Cited: 4

Empagliflozin reduces the adverse effects of diabetes mellitus on testicular tissue in type 2 diabetic Rats: A stereological and biochemical study
Mina Kiani, Malek Soleimani Mehranjani, Seyed Mohammad Ali Shariatzadeh
Biochemical Pharmacology (2024) Vol. 223, pp. 116135-116135
Closed Access | Times Cited: 1

An update on the molecular mechanism and pharmacological interventions for Ischemia-reperfusion injury by regulating AMPK/mTOR signaling pathway in autophagy
Bin Tang, Zhijian Luo, Rong Zhang, et al.
Cellular Signalling (2023) Vol. 107, pp. 110665-110665
Closed Access | Times Cited: 3

Empagliflozin Reverses Oxidized LDL-Induced RECK Suppression, Cardiotrophin-1 Expression, MMP Activation, and Human Aortic Smooth Muscle Cell Proliferation and Migration
Bysani Chandrasekar, Srinivas Mummidi, Vincent G. DeMarco, et al.
Mediators of Inflammation (2023) Vol. 2023, pp. 1-20
Open Access | Times Cited: 2

Sestrin2 in diabetes and diabetic complications
Xiaodan Zhang, Zirui Luo, Jiahong Li, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 2

Complex actions of sodium glucose transporter-2 inhibitors on lipids, calcific atherosclerosis, and bone density
Stuti Pradhan, Sophia Kalanski, Yin Tintut, et al.
Current Opinion in Lipidology (2024) Vol. 35, Iss. 5, pp. 253-257
Closed Access

Sestrin2 knockout exacerbates high-fat diet induced metabolic disorders and complications in female mice
Le Zhang, Chengxia Kan, Junfeng Shi, et al.
Nutrition & Metabolism (2024) Vol. 21, Iss. 1
Open Access

Sestrin2 balances mitophagy and apoptosis through the PINK1-Parkin pathway to attenuate severe acute pancreatitis
Yuxi Yang, Yiqiu Peng, Yingying Li, et al.
Cellular Signalling (2024), pp. 111518-111518
Open Access

Page 1

Scroll to top